I. Introduction
Congenital Heart Disease (CHD) is a type of heart condition that can be detected as early as the first trimester of life [1]. The defect is characterized by abnormalities in the heart structure, which can be mild or severe. CHD is the leading cause of infant mortality, estimated to cause approximately 4–13 deaths per 1000 live births [2]–[4]. Screening and diagnosing CHD during pregnancy is important so that life-saving treatment can be carried out in time. Newborns with severe heart disease who are not examined and diagnosed before birth may face worsening disease symptoms in the delivery room or in the first month of life. Echocardiography is the primary examination for the diagnosis of CHD. It is non-invasive, low-cost, convenient, and suitable for real-time medical imaging. The basic fetal heart screening is interpreted by the apical four-chamber (A4C) view of fetal echocardiography. In fact, although some fetal diseases can be directly visualized in the A4C view, some functional CHD cases cannot be observed, and require organ segmentation and parametric measurements to diagnose. The A4C view of a fetal ultrasound image and the masks of the key anatomical structures are shown in Fig. 1.